Our Product Candidates
AVEO Oncology is committed to discovering, developing and commercializing targeted therapies to treat patients with cancer. We have built a robust pipeline of anti-cancer therapeutics through the use of our proprietary Human Response Platform™.
*AVEO and Astellas Pharma Inc. have a worldwide agreement to co-develop and commercialize tivozanib outside of Asia
**Ficlatuzumab further development focused on external collaborations
***ERBB3 antibody program is strategically partnered with Biogen Idec